Cargando…

Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?

A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chlo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Baretić, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153521/ https://www.ncbi.nlm.nih.gov/pubmed/32315948 http://dx.doi.org/10.1016/j.dsx.2020.04.014

Ejemplares similares

The calcium paradox - What should we have to fear?
por: de Oliveira, Marcos Aurélio Barboza, et al.
Publicado: (2014)

Chloroquine and COVID-19: Should We Care about Ototoxicity?
por: Monteiro, Eduardo Machado Rossi, et al.
Publicado: (2020)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

Chloroquine and hydroxychloroquine during pregnancy: What do we know?
por: Lacroix, Isabelle, et al.
Publicado: (2020)

Hypoglycaemia in Type 2 diabetes
por: Amiel, S A, et al.
Publicado: (2008)

What we have learned from the past and how we should look forward
por: Wellmer, Friedrich-W.
Publicado: (2022)

By What Standard Should We Manage Diabetes?
por: Brunton, Stephen
Publicado: (2018)

Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes: results from Diabetes MILES Youth – The Netherlands
por: Aalders, J., et al.
Publicado: (2018)

AB132. Nocturnal penile tumescence monitoring: what have we done and what should we do?
por: Gao, Liang, et al.
Publicado: (2015)

China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
por: Cheng, Sixiang, et al.
Publicado: (2022)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

CK-MB Elevation in Mild Hypothermia: What We Did and We Should Have Done
por: Sawalha, Khalid, et al.
Publicado: (2021)

Prevalence and predictors of diabetes-related distress in adults with type 1 diabetes
por: Grulovic, Natasa, et al.
Publicado: (2022)

Under the Mind's Hood: What We Have Learned by Watching the Brain at Work
por: Nobre, Anna Christina, et al.
Publicado: (2020)

Should We Treat Prehypertension in Diabetes?: What are the cons?
por: Grossman, Ehud
Publicado: (2009)

People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study
por: Moser, O., et al.
Publicado: (2020)

Supporting hemodynamics: what should we target? What treatments should we use?
por: Gattinoni, Luciano, et al.
Publicado: (2013)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Newly detected diabetes during the COVID-19 pandemic: what have we learnt?
por: Hirani, Dhruti, et al.
Publicado: (2023)

Neoadjuvant Therapy (NAT) in Localized Pancreatic Cancer: Should We Do It and What Should We Do?
por: Goyal, Shreya Prasad, et al.
Publicado: (2021)

What Should We Eat?
Publicado: (1909)

Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka
por: Dissanayake, H. A., et al.
Publicado: (2018)

Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
por: Elvebakk, Ole, et al.
Publicado: (2018)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies, Melanie, et al.
Publicado: (2016)

We should have seen this coming
por: Schwarzkopf, D. Samuel
Publicado: (2014)

COVID-19: What we’ve done well and what we could or should have done better—the 4 Ps
por: Vincent, Jean-Louis, et al.
Publicado: (2021)

Letter to the Editor Regarding: Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Patients in Primary Care
por: Bralić Lang, Valerija, et al.
Publicado: (2020)

COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?
por: Javelot, Hervé, et al.
Publicado: (2020)

Altered functional connectivity during hypoglycaemia in type 1 diabetes
por: Jacob, Peter, et al.
Publicado: (2022)

Diabetes and periodontal disease: What should we learn next?
por: Naruse, Keiko
Publicado: (2014)

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
por: Hope, Suzy V., et al.
Publicado: (2018)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes
por: Dunn, Joel T., et al.
Publicado: (2018)

Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
por: Ali, Namam, et al.
Publicado: (2020)

Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes
por: Bahrami, Jasmine, et al.
Publicado: (2022)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Ambulatory Glucose Profile Changes During Pregnancy in Women With Type 1 Diabetes Using Intermittently Scanned Continuous Glucose Monitoring Empowered by Personalized Education
por: Baretić, Maja, et al.
Publicado: (2023)

COVID-19 pandemic. What have we learned?()
por: Calvo, Cristina, et al.
Publicado: (2021)

Professional Continuous Glucose Monitoring Reveals Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Treated with Oral Antidiabetics
por: Baretić, Maja, et al.
Publicado: (2021)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ldjaejb64herh0kj5h5jmc8lt0